Are We Overdiagnosing ADHD?

How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?

Related Videos
Related Content

Avadel Pharmaceuticals Urges FDA to Make Decision on Extended-Release Formulation of Sodium Oxybate

March 28th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Sodium Oxybate Demonstrates Long-term Safety and Maintained Efficacy in Pediatric Narcolepsy with Cataplexy

March 28th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

Milestone-Free Time Longer in IV Edaravone-Treated Patients With ALS, Administrative Claims Suggest

March 27th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Avadel Pharmaceuticals Urges FDA to Make Decision on Extended-Release Formulation of Sodium Oxybate

March 28th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Sodium Oxybate Demonstrates Long-term Safety and Maintained Efficacy in Pediatric Narcolepsy with Cataplexy

March 28th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

Milestone-Free Time Longer in IV Edaravone-Treated Patients With ALS, Administrative Claims Suggest

March 27th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Avadel Pharmaceuticals Urges FDA to Make Decision on Extended-Release Formulation of Sodium Oxybate

March 28th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Sodium Oxybate Demonstrates Long-term Safety and Maintained Efficacy in Pediatric Narcolepsy with Cataplexy

March 28th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

Milestone-Free Time Longer in IV Edaravone-Treated Patients With ALS, Administrative Claims Suggest

March 27th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023
© 2023 MJH Life Sciences

All rights reserved.